Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Benign prostatic hyperplasia (Doxazosin - Benign prostatic hyperplasia)

Records returned : 16 (on 29 May 2025 at 12:57:19). Return to search results for ' Benign prostatic hyperplasia '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Doxazosin

Drug:

Doxazosin

Indication :

Benign prostatic hyperplasia

Status :

Green

Formulations :

Immediate release tablets

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Doxazosin

Drug:

Doxazosin

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Use immediate release tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

3. Dutasteride

Drug:

Dutasteride

Indication :

Benign prostatic hyperplasia

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Finasteride

Drug:

Finasteride

Indication :

Benign prostatic hyperplasia

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Tamsulosin hydrochloride

Drug:

Tamsulosin hydrochloride

Indication :

Benign prostatic hyperplasia

Status :

Green

Formulations :

Modified release capsules

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Tamsulosin hydrochloride

Drug:

Tamsulosin hydrochloride

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Use modified release capsules

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

6. Alfuzosin hydrochloride

Drug:

Alfuzosin hydrochloride

Indication :

Benign prostatic hyperplasia

Status :

Green (see narrative)

Formulations :

Modified release tablets
Tablets

Restrictions / Comments:

Important

2nd or 3rd line. Tamsulosin MR capsules or Doxazosin immediate release tablets are preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Terazosin hydrochloride

Drug:

Terazosin hydrochloride

Indication :

Benign prostatic hyperplasia

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Restricted for patients with renal or hepatic failure

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Avanafil

Drug:

Avanafil

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

9. Indoramin

Drug:

Indoramin

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

10. Prazosin hydrochloride

Drug:

Prazosin hydrochloride

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

11. Sildenafil

Drug:

Sildenafil

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

12. Tadalafil

Drug:

Tadalafil

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

13. Tamsulosin and dutasteride hydrochloride

Drug:

Tamsulosin and dutasteride hydrochloride

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

15. Tamsulosin with solifenacin

Drug:

Tamsulosin with solifenacin

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

16. Vardenafil

Drug:

Vardenafil

Indication :

Benign prostatic hyperplasia

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1